MedPath

A Randomised Controlled Clinical Trial of Memory Specificity Training (MEST) for Depression

Not Applicable
Completed
Conditions
Depressive Symptoms
Major Depressive Disorder
Interventions
Behavioral: Education and Support
Behavioral: Memory Specificity Training
Registration Number
NCT01882452
Lead Sponsor
Medical Research Council
Brief Summary

Depression involves the tendency to recall overgeneral personal memories, a phenomenon which has been linked to numerous adverse psychological outcomes. The purpose of this study is to investigate whether a group-based Memory Specificity Training (MEST) programme improves outcomes in depression, and how this compares to an education and support control group. The primary aim is to examine whether MEST, which involves repeated practice retrieving specific autobiographical memories reduces depressive symptoms immediately post-treatment, and whether this is maintained 3 months after treatment. The secondary objective of this trial is to examine the role of hypothesised cognitive processes (ie., rumination, executive control, cognitive avoidance) which may underlie improvements in depression and memory.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Principal diagnosis of Major Depressive Disorder
  • History of more than one previous depressive episode
  • Current diagnosis of a Major Depressive Episode
  • Depressive symptoms rated in the mild-severe range (> 13 on the BDI-II)
  • Memory specificity < .70 (as assessed on the AMT)
Exclusion Criteria
  • Head trauma
  • Organic brain damage
  • Secondary diagnosis of another affective disorder
  • Psychosis
  • Current drug or alcohol abuse or dependence
  • A diagnosed Axis II disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Education and SupportEducation and SupportFive weekly one-hour sessions of an education-and-discussion supportive intervention, administered in groups of 5-8 participants.
Memory Specificity TrainingMemory Specificity TrainingFive weekly one-hour sessions of memory specificity training administered in groups of 5-8 participants.
Primary Outcome Measures
NameTimeMethod
Change from baseline in depressive symptoms on the Beck Depression Inventory II (BDI-II)Change from baseline to 3 months post-treatment

Symptom severity score

Secondary Outcome Measures
NameTimeMethod
Change in depressive status according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - IV (SCID-IV)Change from baseline at end of treatment (approximately 6 weeks) and 3 months post-treatment, and 6-months post-treatment (6-month follow-up for MEST group only)

Presence of a current Major Depressive Episode (MDE)

Change from baseline in autobiographical memory specificity on Autobiographical Memory Test (AMT)Change from baseline at end of treatment (approximately 6 weeks) and 3 months post-treatment

Memory specificity level

Change from baseline in depressive symptoms as measured on the BDI-IIChange from baseline to post-treatment (approximately 6-weeks)

Symptom severity score

Depression free days following treatment according to the Longitudinal Follow-up Evaluation on the SCID-IVPost-treatment and 3-month and 6-month follow-up

Number of depression-free days

Trial Locations

Locations (1)

Aliza Werner-Seidler

🇦🇺

Sydney, Australia

© Copyright 2025. All Rights Reserved by MedPath